Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study

Total article views   HTML views PDF downloads Totals
5,288 Dovepress* 4,562+ 110 4,672
PubMed Central* 726 197 923
Totals 5,288 307 5,595
*Since 27 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar